Inpatient Blood Glucose Control in Taichung Veterans General Hospital

NCT ID: NCT02885909

Last Updated: 2020-01-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

600 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be conducted in the ward of Taichung Veterans General Hospital. The patient with hyperglycemia in hospitalization will be enrolled by glucose management team.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will be conducted in the ward of Taichung Veterans General Hospital. The type 2 diabetic patient with hyperglycemia in hospitalization are candidates. The glucose will be controlled using the insulin protocal based on the glucose monitor systems. We will assess the effects of insulin protocal and glucose monitor system on the inpatient with hyperglycemia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HYPERGLYCEMIA

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Insulin protocal with CGM

Insulin protocal with continue glucose monitor

Group Type ACTIVE_COMPARATOR

CONTINUE GLUCOSE MONITOR

Intervention Type DEVICE

Continue glucose monitor

Insulin protocal

Intervention Type PROCEDURE

Using insulin protocal based on glucose monitor

Insulin protocal

Insulin protocal with convential glucose monitor

Group Type ACTIVE_COMPARATOR

Insulin protocal

Intervention Type PROCEDURE

Using insulin protocal based on glucose monitor

Convential treatment

Convential insulin treatment and glucose monitor

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CONTINUE GLUCOSE MONITOR

Continue glucose monitor

Intervention Type DEVICE

Insulin protocal

Using insulin protocal based on glucose monitor

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 2 diabetic inpatient
* Fasting glucose \>140 mg/dl or random glucose \>180 mg/dl

Exclusion Criteria

* incooperative for glucose monitor
* refusal of insulin
* pregnancy
Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Taichung Veterans General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

I-Te Lee, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

Taichung Veterans General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

I-Te Lee, MD, PhD

Role: CONTACT

+886-4-23592525 ext. 4006

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CF16199B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.